RIM
MDCO

RS Investment Management’s Medicines Co MDCO Stock Holding History

RS Investment Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$40.2M Sell
1,195,810
-111,952
-9% -$3.95M 0.41% 81
2016
Q1 		$41.5M Buy
1,307,762
+109,130
+9% +$3.56M 0.41% 83
2015
Q4 		$44.8M Buy
1,198,632
+517,940
+76% +$19.6M 0.4% 91
2015
Q3 		$25.8M Buy
680,692
+313,374
+85% +$11M 0.23% 156
2015
Q2 		$10.5M Buy
367,318
+28,960
+9% +$807K 0.09% 247
2015
Q1 		$9.48M Sell
338,358
-138,640
-29% -$3.89M 0.08% 245
2014
Q4 		$13.2M Sell
476,998
-468
-0.1% -$11.6K 0.12% 225
2014
Q3 		$10.7M Sell
477,466
-7,376
-2% -$187K 0.1% 227
2014
Q2 		$14.1M Sell
484,842
-38,922
-7% -$1.04M 0.12% 207
2014
Q1 		$14.9M Buy
+523,764
New +$17.3M 0.09% 206
2013
Q3 		– Sell
-887,784
Closed -$27.3M – 343
2013
Q2 		$27.3M Buy
+887,784
New +$29.7M 0.2% 138

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RS Investment Management's MDCO Position: Q2 2016 in Review

RS Investment Management reduced its Medicines Co (MDCO) stake by 8.6% in Q2 2016, selling an estimated $3.95M and leaving 1,195,810 shares worth $40.2M. The position accounts for 0.41% of the portfolio, ranked #81.

RS Investment Management first reported a position in MDCO in Q2 2013 and has held it in 11 quarters since. The position peaked at $44.8M in Q4 2015. 190 funds tracked by Wall St. Rank hold MDCO as of Q2 2016.

  • RS Investment Management held 1,195,810 shares of Medicines Co worth $40.2M as of Q2 2016.
  • RS Investment Management sold 111,952 Medicines Co shares in Q2 2016, an estimated $3.95M.
  • Medicines Co made up 0.41% of RS Investment Management's portfolio in Q2 2016, its #81 holding.
  • RS Investment Management first reported a position in Medicines Co in Q2 2013 and has held it in 11 quarters since.
  • RS Investment Management's Medicines Co position peaked at $44.8M in Q4 2015.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.